Drug points: Dysgeusia and burning mouth syndrome by eprosartan.
Castells
Xavier
X
Fundacia Institut Catala de Farmacologia, Servei de Farmacologica Clinica Hospital, Universitari Vall d'Hebron, 08035, Barcelona, Spain.
Rodoreda
Isidre
I
Pedrós
Consuelo
C
Cereza
Gloria
G
Laporte
Joan-Ramon
JR
D000179:Acrylates / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002054:Burning Mouth Syndrome / Q000139:chemically induced*; D004408:Dysgeusia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008875:Middle Aged; D013876:Thiophenes
D000179:Acrylates; D000959:Antihypertensive Agents; D007093:Imidazoles; D013876:Thiophenes; C068373:eprosartan